Intelligent Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) and Plus Therapeutics (NASDAQ:PSTV – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Earnings and Valuation This table compares […]

Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) and Plus Therapeutics (NASDAQ:PSTV – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Analyst Recommendations This is a breakdown […]

Intelligent Bio Solutions reported revenue from sales of goods increased by $400,000 from $360,000 to $760,000 for the quarter ended Dec. 31, 2023, representing a 114% increase year-over-year. Revenue from sales of goods increased by $1.2 million from $360,000 to $1.56 million for the six months ended Dec. 31, 2023, representing a 337% increase year-over-year.

Intelligent Bio Solutions witnesses a significant surge, expecting a 337% YoY revenue increase for H2 2023 and a 114% increase in Q2, attributing the growth to drug screening solution awareness, market expansion, and global footprint extension.

Intelligent Bio Solutions shares are moving on very heavy trading volume with more than 46.4 million shares already traded in the session. According to data from Benzinga Pro, the stock has a float of only 726,316 shares after the stock effected a 1-for-12 reverse split on Monday. Intelligent Bio Solutions shares have a significant amount of short interest. 45.66% of shares being sold short which, when combined with the heavy trading volume, may be contributing to the stock's large move on Friday.